Loading…
Alamar Biosciences, Inc. is projected to decline to $18.58 by 2027, a -3% move from its current price of $19.12.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $18.51 | $19.13 | $19.76 | +0.04% |
| May 30 | $18.27 | $19.14 | $20.04 | +0.09% |
| May 31 | $18.09 | $19.15 | $20.26 | +0.13% |
| Jun 1 | $17.94 | $19.15 | $20.45 | +0.18% |
| Jun 2 | $17.81 | $19.16 | $20.61 | +0.22% |
| Jun 3 | $17.70 | $19.17 | $20.77 | +0.27% |
| Jun 4 | $17.59 | $19.18 | $20.91 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.59 | $19.18 | $20.91 | +0.31% |
| Week 2 | $17.03 | $19.24 | $21.74 | +0.63% |
| Week 3 | $16.62 | $19.30 | $22.42 | +0.94% |
| Week 4 | $16.29 | $19.36 | $23.01 | +1.26% |
| Week 5 | $16.01 | $19.42 | $23.56 | +1.57% |
| Week 6 | $15.77 | $19.48 | $24.07 | +1.89% |
| Week 7 | $15.55 | $19.54 | $24.56 | +2.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alamar Biosciences, Inc. is a healthcare company focused on proteomics. It develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early disease detection. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Alamar offers the ARGO high throughput (HT) System, a fully automated precision proteomics platform, which performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and diagnostics.
The company was incorporated in 2018 and is based in Fremont, California.
Alamar Biosciences, Inc. (ALMR) operates in the healthcare sector with a focus on proteomics. Its current price is $20.06 and its market cap is $1.39B, placing it at rank 2289.
The forecast horizon shows a path from a near-term price around the current level toward higher levels later. The 2026 average price is $20.06 with a max of $26.94, and the 30-day forecast range spans from $16.08 to $25.02, indicating modest near-term upside but notable variance.
Longer term, the model envisions growing averages into the late 2020s and beyond, with 2030 average of $26.24 and 2030 max of $44.88, climbing to 2040 average of $40.81 and 2050 average of $67.41, with corresponding max values of $87.32 and $155.04 respectively.
A major floor 0.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.2% away) — a key level to hold.
The nearest ceiling, 39.6% above — a clean break opens room to run.
A major ceiling 39.6% above — clearing it would confirm fresh momentum.
Key ALMR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.09 | $19.12 | $25.20 | 0% | Neutral | |
| $13.60 | $18.58 | $27.41 | -3% | Neutral | |
| $12.26 | $17.67 | $27.61 | -8% | Neutral | |
| $13.40 | $20.21 | $33.02 | +6% | Neutral | |
| $14.30 | $22.49 | $38.12 | +18% | Neutral | |
| $14.33 | $23.43 | $41.01 | +23% | Bullish | |
| $14.62 | $24.80 | $44.67 | +30% | Bullish | |
| $13.51 | $23.74 | $43.87 | +24% | Bullish | |
| $12.58 | $22.89 | $43.30 | +20% | Neutral | |
| $12.29 | $23.12 | $44.69 | +21% | Bullish | |
| $15.27 | $33.72 | $71.27 | +76% | Bullish | |
| $23.28 | $51.74 | $119.01 | +171% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $19.09 | $19.12 | $22.80 | +0.00% |
| June 2026 | $16.79 | $20.07 | $24.80 | +4.95% |
| July 2026 | $16.41 | $19.91 | $25.19 | -0.76% |
| August 2026 | $16.00 | $19.65 | $25.31 | -1.31% |
| September 2026 | $16.20 | $20.10 | $26.26 | +2.26% |
| October 2026 | $15.94 | $19.96 | $26.42 | -0.67% |
| November 2026 | $15.02 | $18.97 | $25.39 | -5.00% |
| December 2026 | $14.64 | $18.63 | $25.20 | -1.78% |
Click any year to see its month-by-month ALMR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ALMR is projected to trade between $19.09 and $25.20, averaging $19.12 — a potential gain of 0% from today's $19.12. A consolidation phase looks the most probable path here.
Alamar Biosciences, Inc.'s 2027 outlook centres on $18.58, within a $13.60 to $27.41 range. That is -3% versus the projected 2026 average. That marks a -3% change versus current levels. Price action looks broadly range-bound.
By 2028, ALMR could reach as high as $27.61, with a base case around $17.67 and support toward $12.26 — roughly -8% from $19.12. A consolidation phase looks the most probable path here.
Expect ALMR to range from $13.40 to $33.02 through 2029. The $20.21 average target implies a +6% move from current prices. That is up +14% on the projected 2028 average. Price action looks broadly range-bound.
The ALMR price prediction for 2030 points to an average of $22.49 (low $14.30, high $38.12) — a potential gain of +18% on today's $19.12. A consolidation phase looks the most probable path here.
In 2031, ALMR is projected to trade between $14.33 and $41.01, averaging $23.43 — a potential gain of +23% from today's $19.12. That is up +4% on the projected 2030 average. Momentum favours further upside here.
Alamar Biosciences, Inc.'s 2032 outlook centres on $24.80, within a $14.62 to $44.67 range. That is up +6% on the projected 2031 average. That marks a +30% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ALMR could reach as high as $43.87, with a base case around $23.74 and support toward $13.51 — roughly +24% from $19.12. Momentum favours further upside here.
Expect ALMR to range from $12.58 to $43.30 through 2034. The $22.89 average target implies a +20% move from current prices. That is -4% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The ALMR price prediction for 2035 points to an average of $23.12 (low $12.29, high $44.69) — a potential gain of +21% on today's $19.12. Momentum favours further upside here.
In 2040, ALMR is projected to trade between $15.27 and $71.27, averaging $33.72 — a potential gain of +76% from today's $19.12. That is up +46% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Alamar Biosciences, Inc.'s 2050 outlook centres on $51.74, within a $23.28 to $119.01 range. That is up +53% on the projected 2040 average. That marks a +171% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ALMR today (≈ 52.301255 ALMR) could be worth
$2,706.22
+$1,706.22 (+171%) by 2050 · US Dollar
Based on the average projected ALMR price of $51.74 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALMRwould be worth at today's price.
$1,000 invested in ALMR on Apr 17, 2026 (≈ 45.454545 ALMR) would be worth
$869.09
-$130.91 (-13.1%) today · 0.87× · US Dollar
Based on a ALMR entry price of $22 vs. today's $19.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $20.16 | $948.41 | -5.2% |
| 1 month ago | $26.69 | $716.37 | -28.4% |
| All time ago | $22 | $869.09 | -13.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALMR forecast.
Our base-case forecast reaches $38.00 around 2050.
Implied market cap at $38.00: $2.63B
The multi-year forecast shows a bullish trajectory from 2030 onward. The 2030 average is $26.24 with a max of $44.88 and an ROI of 30.8%, followed by 2031 average of $26.89 and 2032 average of $28.90, reaching 2035 average of $28.00. This pathway suggests continued upside into the mid-2020s, with higher tops in the late 2030s.
By 2040 the average is forecast at $40.81 with an ROI of 103.5%, and by 2050 the average is $67.41 with an ROI of 236%. The 2040 max is $87.32 and the 2050 max is $155.04, indicating substantial long-term upside potential despite near-term uncertainty.
These figures are estimates, not guarantees, and subject to market and company-specific risks.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $26.24, with a low of $16.51 and a high of $44.88, and an ROI of 30.8%; sentiment is BULLISH.
The long-term forecast shows bullish potential, with 2030 average $26.24 and 2050 average $67.41 and ROI up to 236%, though near-term figures (e.g., 2026 average $20.06; 2026 max $26.94) indicate mixed, cautious momentum.
According to the forecast, the 2050 max is $155.04, which would exceed $100, but these are estimates and not guarantees.
Sentiment is NEUTRAL; RSI(14) is 40. The 30-day range is $16.08–$25.02, with support at $20.06 and resistance at $26.69; annualized volatility is 60%.
Current price is $20.06 and market cap is $1.39B; the rank is 2289.
Alamar Biosciences, Inc. Community Discussion
0Share your Alamar Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.